GTCM
IDYA icon

Gyon Technologies Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Gyon Technologies Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,721
Closed -$158K – 195
2022
Q4 		$158K Sell
8,721
-5,131
-37% -$86.3K 0.06% 320
2022
Q3 		$207K Buy
+13,852
New +$180K 0.06% 325

Other funds holding IDYA

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gyon Technologies Capital Management's IDYA Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of IDEAYA Biosciences (IDYA) in Q1 2023, closing a stake of 8,721 shares — an estimated $158K sold.

Gyon Technologies Capital Management first reported a position in IDYA in Q3 2022 and held it in 2 quarters. The position peaked at $207K in Q3 2022. 128 funds tracked by Wall St. Rank hold IDYA as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining IDEAYA Biosciences position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 8,721 IDEAYA Biosciences shares in Q1 2023, an estimated $158K.
  • Gyon Technologies Capital Management first reported a position in IDEAYA Biosciences in Q3 2022 and held it in 2 quarters.
  • Gyon Technologies Capital Management's IDEAYA Biosciences position peaked at $207K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.